Estadisticas : Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine Inamdar, Kedar V.
Visitas:480
280 ( Estados Unidos de América )
62 ( Singapur )
31 ( Hong kong )
23 ( Reino Unido )
20 ( China )
16 ( Brasil )
13 ( Letonia )
8 ( Irlanda )
7 ( Alemania )
4 ( Canadá )
4 ( Vietnam )
3 ( Austria )
2 ( Francia )
2 ( Argentina )
1 ( Guatemala )
1 ( Irak )
1 ( Arabia Saudita )
1 ( México )
1 ( Irán )
Descargas: 0